Institutional investors control 16.21% of the outstanding shares in AZN. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended June 2019, these large investors purchased a net $8.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SANDERS CAPITAL LLC Bought 10.6 Million shares of AstraZeneca PLC
VOYA INVESTMENT MANAGEMENT CO. L... Bought 2.7 Million shares of AstraZeneca PLC
MANAGED ACCOUNT ADVISORS LLC Bought 2.0 Million shares of AstraZeneca PLC